Skip to main content
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in:

Open Access 01-12-2025 | Human Immunodeficiency Virus | Correction

Correction: After the program ends: HIV testing behavior among men who have sex with men after the conclusion of a program providing regular home delivery of HIV self-testing kits

Authors: Tyler B. Wray, Philip A. Chan, Jeffrey D. Klausner, Lori M. Ward, Erik M. S. Ocean

Published in: BMC Infectious Diseases | Issue 1/2025

Login to get access

Excerpt

Correction: Wray et al. BMC Infectious Diseases (2025) 25:462 …
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Correction: After the program ends: HIV testing behavior among men who have sex with men after the conclusion of a program providing regular home delivery of HIV self-testing kits
Authors
Tyler B. Wray
Philip A. Chan
Jeffrey D. Klausner
Lori M. Ward
Erik M. S. Ocean
Publication date
01-12-2025
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2025
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-025-11042-x

Other articles of this Issue 1/2025

The combined manifestations of dramatically sore throat, congested and edematous mucosa, no-swelling tonsil are specific in acute Omicron pharyngitis

Time trend and identification of risk areas for physical disability due to leprosy in Brazil: An ecological study, 2001-2022

Risk factors for poor outcomes in patients with drug-resistant tuberculosis: a 6-year multicenter prospective study in Zhejiang, China

Prevalence of protozoa in HIV/AIDS patients with Gastrointestinal symptoms in Zinder National Hospital, Niger Republic

Advancing the understanding and management of Mpox: insights into epidemiology, disease pathways, prevention, and therapeutic strategies

  • Open Access
  • Mpox
  • Review

Epidemiology of dengue fever in Somaliland: clinical features, and serological patterns from a retrospective study

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025: the 85th Scientific Sessions

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s annual meeting.

Read more
Image Credits